A new state law requires all holders of a controlled substance registration (CSR) to register with INSPECT, Indiana’s prescription drug monitoring program, by Jan. 1. Failure to register is a Class A misdemeanor. Also starting Jan. 1, CSR holders in hospital EDs and pain clinics must query INSPECT before prescribing or dispensing opioids or benzodiazepines. To see these and other important dates for INSPECT law compliance, visit www.ismanet.org/pdf/INSPECT2019.pdf.

Also, plan to attend our free CME webinar Jan. 17. Stacy Cook, JD, of Barnes & Thornburg LLC, will give an update on new Iaws regarding mandatory INSPECT registration and queries, as well as the new opioid CME requirement. Learn more: www.ismanet.org/LegalUpdate1-17-19